Skip to main content

Displaying 3901 - 3920 of 4596

Announced Action for February 11, 2005

Date
Commission authorization of the staff to file amicus brief: The Commission has authorized the staff to file a brief as amicus curiae in Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc., Case No. 04-1186...

Announced Action for February 4, 2005

Date
Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter concerning Genzyme Corporation and ILEX Oncology, Inc...

Genzyme Corporation and Ilex Oncology, Inc., In the Matter of

A consent order allowed Genzyme’s acquisition of ILEX Oncology, Inc., but requires the companies to divest certain assets in the market for solid organ transplant acute therapy drugs. Specifically, Genzyme is required to divest all contractual rights related to ILEX’s Campath®, an immunosuppressant antibody used in solid organ transplants to Schering AG.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410083
Jan14

Oil Industry Merger Effects

The FTC hosted a public conference to examine two recent studies focusing on the price effects of mergers and concentration in the United States petroleum industry. The conference brought together a...

Announced Actions for January 14, 2005

Date
The Commission has approved a petition for proposed divestiture received from General Electric Company (GE) and related to the FTC decision and order regarding GE’s acquisition of InVision...

General Electric Company, In the Matter of

General Electric was permitted to acquire InVision Technologies, Inc. with conditions that it divest InVision's YXLON x-ray nondestructive testing and inspection equipment to a Commission approved acquirer. According to the complaint issued with the consent order, the two firms are direct competitors in a highly concentrated market. The consent order protects competition in the United States market for specialized x-ray testing and inspection including standard x-ray cabinets; x-ray systems equipped with automated defect recognition software; and high-energy x-ray generators.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410106
Docket Number
C-4119

Cephalon, Inc., and CIMA Labs, Inc.

The consent order settled charges that Cephalon's proposed acquisition of Cima Labs, Inc. would allow Cephalon to continue its monopoly in the United States market for drugs that eliminate or reduce the spikes of severe pain that chronic cancer patients experience. The consent order required Cephalon to grant Barr Laboratories, Inc. a fully paid, irrevocable license to make and sell a generic version of Cephalon's breakthrough cancer pain drug, Actiq, in the United States.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410025

Buckeye Partners, L.P., and Shell Oil Company, In the Matter of

The consent order settled charges that Buckeye's proposed acquisition of five refined petroleum products pipelines and 24 petroleum products terminals in the United States from Shell Oil Company would reduce competition in the market for the terminaling of gasoline, diesel fuel, and other light petroleum products in the area of Niles, Michigan. Buckeye agreed to notify the Commission before acquiring any interest in the Niles petroleum terminal for a period of ten years.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410162

Sanofi-Synthelabo and Aventis, In the Matter of

The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of Aventis would create significant overlaps in several markets for pharmaceutical products while creating the world's third largest pharmaceutical company. Under terms of the consent order, Sanofi must: 1) divest its Arixtra factor Xa inhibitor to GlaxoSmithKline, plc; 2) divest its key clinical studies for the Campto® cytotoxic colorectal cancer treatment to Pfizer, Inc. and 3) divest Aventis' contractual rights to the Estorra insomnia drug either to Sepracor, Inc. or to another Commission-approved buyer.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
041 0031
Docket Number
C-4112

American Air Liquide, Inc.

L’Air Liquide was permitted to acquire Messer Griesheim GmbH, a leading industrial gas producer. Under terms of the order, Air Liquide is required to divest six air separation units operated by Messer in California, Texas, Louisiana, and Mississippi within six months. According to the complaint, the transaction as proposed would substantially lessen competition in the market for liquid argon, liquid oxygen and liquid nitrogen.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410020
Docket Number
C-4109

Virginia Board of Funeral Directors and Embalmers

The Virginia Board of Funeral Directors and Embalmers settled charges that it prohibited Virginia funeral directors and service providers from engaging in truthful advertising that would inform consumers of prices and discounts for funeral products and services. Under terms of the consent order, the Board is prohibited from engaging in such practices in the future and is required to amend its regulation prohibiting Board licensees from advertising funeral services including those services that can be contracted prior to the death of the person whose funeral is being planned.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410014